Arrevus, Inc. reported raising $300,000 in an initial SEC Form D filing, from an offering of $600,000
Amount Raised
$300,000
Round Type
Seed
RaleighBiotechnologyQuick answer
Arrevus, Inc. raised $300,000 in a Seed round, dated August 3, 2018. Arrevus, Inc. is based in Raleigh, North Carolina, United States.
- How much did Arrevus, Inc. raise?
- Arrevus, Inc. raised $300,000 in a Seed round on August 3, 2018.
- What does Arrevus, Inc. do?
- Arrevus is a Research Triangle Park-based biotech company.
- Where is Arrevus, Inc. based and how big is it?
- Arrevus, Inc. is based in Raleigh, North Carolina, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Arrevus, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Inscripta raised $1.1M (Seed) on September 17, 2018.
- Euphrates Vascular, Inc. raised $590K (Seed) on September 17, 2018.
- Propanc Biopharma raised $158K (Pre-Seed) on September 17, 2018.
- MARIZYME INC raised $15M on September 17, 2018.
- BiOWiSH Technologies raised $7.5M on September 14, 2018.
- Artelo Biosciences raised $526K on September 14, 2018.
Who to call at Arrevus, Inc., and when
A new round usually means Arrevus, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Arrevus, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Arrevus, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Arrevus, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Arrevus, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Arrevus, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.